A review of the background of biosensors which utilise osmium complexes for monitoring the glucose levels in diabetic patients is presented. An electrochemical system, based on an osmium redox polymer, is described; the system is aimed at being a reliable, compact and miniature in vivo sensor for implantation into diabetic patients for continuous monitoring of their blood glucose levels. The sensor is about to begin trials on human volunteers.
No takes yet. Share an insight, caveat, or question.
Timothy J. Ohara (1995) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: